Trial Profile
Phase IV Study of the Use of Sequential DFP-DFO Versus DFP in Thalassemia Major Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary) ; Deferoxamine (Primary)
- Indications Thalassaemia
- Focus Therapeutic Use
- 01 Jul 2015 Results published in the American Journal of Hematology.
- 05 Sep 2008 New trial record.